(19)
(11) EP 1 214 429 A1

(12)

(43) Date of publication:
19.06.2002 Bulletin 2002/25

(21) Application number: 00968378.0

(22) Date of filing: 21.09.2000
(51) International Patent Classification (IPC)7C12N 15/67, C12Q 1/68, G01N 33/50
// (C12N15/12, C07K14:735, C12N5:10, A01K67:027, A61K38:17)
(86) International application number:
PCT/US0025/877
(87) International publication number:
WO 0121/816 (29.03.2001 Gazette 2001/13)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.09.1999 US 154924 P

(71) Applicants:
  • ISIS INNOVATION LIMITED
    Summertown,Oxford OX2 7BZ (GB)
  • Beth Israel Deaconess Medical Center, Inc.
    Boston, MA 02215 (US)

(72) Inventors:
  • KINET, Jean-Pierre
    Lexington, MA 02421 (US)
  • DONNADIEU, Emmanuel
    F-92100 Boulogne (FR)
  • JOUVIN, Marie-Helene
    Brookline, MA 02446 (US)
  • COOKSON, William
    Oxford OX3 9DU (GB)
  • MOFFATT, Miriam Fleur
    Bicester,Oxon OX6 0XR (GB)

(74) Representative: Baldock, Sharon Claire et al
BOULT WADE TENNANT,Verulam Gardens70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)

   


(54) MODULATION OF IGE RECEPTOR CELL SURFACE EXPRESSION